Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity. (Q42117984)
Jump to navigation
Jump to search
scientific article published on 27 August 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity. |
scientific article published on 27 August 2013 |
Statements
Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via D-serine and adenosine receptor type A2 (A2AR) activity (English)
Maria Scianni
Letizia Antonilli
Giuseppina Chece
Gloria Cristalli
Maria Amalia Di Castro
27 August 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference